In a reciprocal way, AML cells release inflammatory cytokines that activate the vascular endothelium, inducing the expression of such adhesion molecules as VCAM1, promoting AML proliferation and chemoresistance (165, 166). This evidence concerns the gene VCAM1 and acute myeloid leukemia.